Vitalibis Inc VCBD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Market Cap
- $227.44
- Volume/Avg
- 7.4 Mil / 502,003
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vitalibis Inc operates in the medicinal cannabis industry through promoting health and wellness. It is engaged in developing Cannabidiol oil, along with personal care and nutritional products formulated with premium hemp extracts. Some of its products include Soothing Duo; Wellness Duo; Actual being Focus; Natural Recovery Greens and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.vitalibis.com
Valuation
Metric
|
VCBD
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
VCBD
|
---|---|
Quick Ratio | 0.06 |
Current Ratio | 5.03 |
Interest Coverage | −2.66 |
Quick Ratio
VCBD
Profitability
Metric
|
VCBD
|
---|---|
Return on Assets (Normalized) | −756.68% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VCBD
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fywdvzqbs | Dhhynhf | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Bnlzzhbcb | Ptlrf | $68.3 Bil | |
HLN
| Haleon PLC ADR | Lxxxqhhj | Qtmt | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cbmbpjzb | Hkks | $14.5 Bil | |
VTRS
| Viatris Inc | Ddbbkrgvb | Zyzd | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hrvddcxmk | Flh | $11.9 Bil | |
CTLT
| Catalent Inc | Cbtywwys | Vdrpkhs | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nkgkbbg | Kdcvr | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bcssrcld | Yfj | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qxbvlmdgb | Mmygblv | $3.5 Bil |